AM Investment Strategies LLC Acquires New Stake in The Clorox Company (NYSE:CLX)

AM Investment Strategies LLC acquired a new stake in shares of The Clorox Company (NYSE:CLX) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 1,481 shares of the company’s stock, valued at approximately $211,000.

Several other large investors also recently added to or reduced their stakes in the business. First National Bank of Mount Dora Trust Investment Services boosted its stake in Clorox by 3.2% during the fourth quarter. First National Bank of Mount Dora Trust Investment Services now owns 2,257 shares of the company’s stock valued at $322,000 after buying an additional 71 shares during the period. Modera Wealth Management LLC boosted its stake in Clorox by 1.4% during the third quarter. Modera Wealth Management LLC now owns 5,130 shares of the company’s stock valued at $672,000 after buying an additional 71 shares during the period. Czech National Bank boosted its stake in Clorox by 0.3% during the fourth quarter. Czech National Bank now owns 21,718 shares of the company’s stock valued at $3,097,000 after buying an additional 71 shares during the period. Global Retirement Partners LLC boosted its stake in Clorox by 7.2% during the fourth quarter. Global Retirement Partners LLC now owns 1,089 shares of the company’s stock valued at $156,000 after buying an additional 73 shares during the period. Finally, West Branch Capital LLC raised its position in Clorox by 9.3% during the fourth quarter. West Branch Capital LLC now owns 903 shares of the company’s stock valued at $129,000 after purchasing an additional 77 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Trading Down 0.2 %

NYSE:CLX traded down $0.27 during mid-day trading on Thursday, reaching $147.51. 1,147,198 shares of the company’s stock traded hands, compared to its average volume of 1,204,423. The Clorox Company has a 12-month low of $114.68 and a 12-month high of $178.21. The firm has a market capitalization of $18.31 billion, a price-to-earnings ratio of 234.15, a PEG ratio of 2.31 and a beta of 0.43. The company has a debt-to-equity ratio of 11.37, a current ratio of 0.89 and a quick ratio of 0.57. The company has a 50 day moving average price of $149.48 and a 200-day moving average price of $142.31.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Thursday, February 1st. The company reported $2.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.08 by $1.08. The company had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $1.80 billion. Clorox had a return on equity of 319.41% and a net margin of 1.09%. Clorox’s revenue was up 16.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.98 EPS. On average, sell-side analysts predict that The Clorox Company will post 5.52 earnings per share for the current year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Wednesday, April 24th will be given a $1.20 dividend. The ex-dividend date of this dividend is Tuesday, April 23rd. This represents a $4.80 dividend on an annualized basis and a dividend yield of 3.25%. Clorox’s dividend payout ratio is currently 761.92%.

Analyst Upgrades and Downgrades

CLX has been the topic of a number of research reports. Deutsche Bank Aktiengesellschaft lowered their price target on Clorox from $155.00 to $151.00 and set a “hold” rating on the stock in a research report on Wednesday, April 17th. Morgan Stanley restated an “equal weight” rating and set a $160.00 price target on shares of Clorox in a research report on Tuesday, March 26th. UBS Group raised their price target on Clorox from $145.00 to $170.00 and gave the company a “neutral” rating in a research report on Friday, February 2nd. DA Davidson restated a “neutral” rating and set a $162.00 price target on shares of Clorox in a research report on Wednesday, April 17th. Finally, Barclays lowered their price target on Clorox from $148.00 to $136.00 and set an “underweight” rating on the stock in a research report on Wednesday, April 10th. Four equities research analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $148.63.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.